Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mast Cells | 63 | 2024 | 1392 | 9.340 |
Why?
|
Asthma, Aspirin-Induced | 19 | 2024 | 202 | 6.480 |
Why?
|
Leukotrienes | 24 | 2022 | 231 | 5.250 |
Why?
|
Receptors, Leukotriene | 21 | 2022 | 95 | 5.120 |
Why?
|
Dinoprostone | 13 | 2024 | 597 | 3.340 |
Why?
|
Receptors, Purinergic P2 | 8 | 2022 | 150 | 2.730 |
Why?
|
Peanut Hypersensitivity | 6 | 2017 | 219 | 2.660 |
Why?
|
Cysteine | 15 | 2021 | 891 | 2.400 |
Why?
|
Hypersensitivity | 16 | 2024 | 1167 | 2.090 |
Why?
|
Immunoglobulin E | 18 | 2021 | 1502 | 2.040 |
Why?
|
Aspirin | 17 | 2023 | 3127 | 1.990 |
Why?
|
Nasal Polyps | 9 | 2023 | 395 | 1.990 |
Why?
|
Leukotriene C4 | 6 | 2020 | 79 | 1.930 |
Why?
|
Sinusitis | 10 | 2023 | 991 | 1.930 |
Why?
|
Asthma | 28 | 2024 | 6233 | 1.910 |
Why?
|
Leukotriene E4 | 13 | 2023 | 75 | 1.860 |
Why?
|
Blood Platelets | 9 | 2020 | 2478 | 1.800 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 11 | 2017 | 63 | 1.790 |
Why?
|
Food Hypersensitivity | 9 | 2017 | 726 | 1.580 |
Why?
|
Th2 Cells | 14 | 2024 | 1056 | 1.550 |
Why?
|
Interleukin-4 | 9 | 2023 | 1146 | 1.440 |
Why?
|
Leukotriene D4 | 7 | 2022 | 33 | 1.420 |
Why?
|
Antigens, Dermatophagoides | 7 | 2019 | 98 | 1.410 |
Why?
|
Eicosanoids | 7 | 2023 | 282 | 1.320 |
Why?
|
Eosinophils | 12 | 2017 | 953 | 1.270 |
Why?
|
Lung | 18 | 2024 | 9998 | 1.240 |
Why?
|
Platelet Activation | 5 | 2023 | 646 | 1.170 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 5 | 2024 | 48 | 1.150 |
Why?
|
Cyclooxygenase 1 | 4 | 2022 | 97 | 1.050 |
Why?
|
Pulmonary Eosinophilia | 6 | 2020 | 78 | 0.980 |
Why?
|
Mice, Knockout | 25 | 2024 | 14389 | 0.970 |
Why?
|
Pneumonia | 10 | 2024 | 2143 | 0.970 |
Why?
|
Lysophospholipids | 4 | 2011 | 337 | 0.940 |
Why?
|
Allergens | 10 | 2019 | 1429 | 0.930 |
Why?
|
Cytokines | 25 | 2024 | 7373 | 0.930 |
Why?
|
Nasal Mucosa | 5 | 2024 | 415 | 0.860 |
Why?
|
Receptors, Purinergic P2Y12 | 4 | 2018 | 115 | 0.820 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2022 | 63 | 0.810 |
Why?
|
Respiratory Tract Diseases | 4 | 2021 | 750 | 0.790 |
Why?
|
Thromboxane A2 | 4 | 2015 | 88 | 0.770 |
Why?
|
NFATC Transcription Factors | 2 | 2022 | 389 | 0.760 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2022 | 84 | 0.760 |
Why?
|
Inflammation | 18 | 2024 | 10760 | 0.750 |
Why?
|
Prostaglandins | 2 | 2023 | 398 | 0.750 |
Why?
|
Intramolecular Oxidoreductases | 4 | 2015 | 105 | 0.740 |
Why?
|
Rhinitis | 5 | 2023 | 747 | 0.740 |
Why?
|
Bronchial Hyperreactivity | 7 | 2017 | 302 | 0.730 |
Why?
|
Mastocytosis | 2 | 2022 | 150 | 0.720 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 5 | 2018 | 614 | 0.710 |
Why?
|
Prostaglandin D2 | 6 | 2016 | 108 | 0.710 |
Why?
|
Stem Cell Factor | 9 | 2011 | 195 | 0.670 |
Why?
|
Pyroglyphidae | 3 | 2015 | 89 | 0.660 |
Why?
|
Macrophages, Alveolar | 2 | 2019 | 411 | 0.640 |
Why?
|
Animals | 75 | 2024 | 168201 | 0.640 |
Why?
|
Autocrine Communication | 3 | 2013 | 169 | 0.630 |
Why?
|
Membrane Proteins | 11 | 2018 | 7847 | 0.620 |
Why?
|
Glutathione Transferase | 6 | 2017 | 565 | 0.600 |
Why?
|
Interleukin-13 | 6 | 2023 | 392 | 0.600 |
Why?
|
Interleukin-5 | 7 | 2020 | 269 | 0.600 |
Why?
|
Immune System Diseases | 2 | 2018 | 254 | 0.590 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2018 | 361 | 0.590 |
Why?
|
Mice | 52 | 2024 | 81368 | 0.590 |
Why?
|
Granulocytes | 3 | 2014 | 551 | 0.580 |
Why?
|
HMGB1 Protein | 1 | 2019 | 136 | 0.580 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2017 | 44 | 0.570 |
Why?
|
Cyclic AMP | 3 | 2017 | 1463 | 0.550 |
Why?
|
Signal Transduction | 22 | 2024 | 23416 | 0.540 |
Why?
|
Leukotriene Antagonists | 6 | 2022 | 124 | 0.540 |
Why?
|
Cells, Cultured | 29 | 2024 | 18937 | 0.530 |
Why?
|
Dietetics | 2 | 2017 | 34 | 0.510 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2018 | 284 | 0.510 |
Why?
|
Uridine Diphosphate | 3 | 2022 | 33 | 0.500 |
Why?
|
Paracrine Communication | 2 | 2007 | 277 | 0.490 |
Why?
|
Practice Guidelines as Topic | 5 | 2017 | 7389 | 0.490 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2017 | 292 | 0.480 |
Why?
|
Receptors, Chemokine | 6 | 2007 | 652 | 0.480 |
Why?
|
Skin Tests | 4 | 2017 | 637 | 0.470 |
Why?
|
Tryptases | 6 | 2022 | 176 | 0.460 |
Why?
|
Epithelial Cells | 8 | 2024 | 3672 | 0.450 |
Why?
|
Mice, Inbred C57BL | 19 | 2024 | 22115 | 0.450 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2023 | 3204 | 0.450 |
Why?
|
Oxazoles | 1 | 2015 | 199 | 0.450 |
Why?
|
Inflammation Mediators | 3 | 2012 | 1884 | 0.450 |
Why?
|
Macrophages | 8 | 2024 | 5758 | 0.430 |
Why?
|
Eosinophilia | 6 | 2017 | 559 | 0.430 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 569 | 0.430 |
Why?
|
Receptors, Lysophosphatidic Acid | 2 | 2011 | 77 | 0.430 |
Why?
|
Adaptive Immunity | 1 | 2018 | 724 | 0.420 |
Why?
|
Receptors, Interleukin-17 | 1 | 2013 | 82 | 0.420 |
Why?
|
Humans | 125 | 2024 | 760617 | 0.410 |
Why?
|
Respiratory Hypersensitivity | 2 | 2011 | 274 | 0.410 |
Why?
|
Chemokine CCL4 | 2 | 2013 | 126 | 0.400 |
Why?
|
Immune System | 3 | 2010 | 791 | 0.390 |
Why?
|
Basophils | 4 | 2014 | 407 | 0.390 |
Why?
|
Receptors, Thromboxane | 3 | 2023 | 30 | 0.380 |
Why?
|
Immunity, Cellular | 3 | 2006 | 1550 | 0.380 |
Why?
|
Fetal Blood | 9 | 2005 | 1347 | 0.380 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2013 | 321 | 0.370 |
Why?
|
Thiophenes | 1 | 2015 | 569 | 0.360 |
Why?
|
Mycophenolic Acid | 1 | 2012 | 349 | 0.350 |
Why?
|
Stem Cells | 6 | 2022 | 3516 | 0.330 |
Why?
|
Immunity, Innate | 2 | 2015 | 3045 | 0.330 |
Why?
|
Primary Prevention | 1 | 2017 | 1185 | 0.320 |
Why?
|
Respiratory Mucosa | 3 | 2021 | 438 | 0.320 |
Why?
|
Tacrolimus | 1 | 2012 | 733 | 0.320 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 4 | 2015 | 691 | 0.320 |
Why?
|
Homeostasis | 3 | 2023 | 3321 | 0.310 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 2009 | 355 | 0.310 |
Why?
|
Chemokines | 3 | 2009 | 954 | 0.300 |
Why?
|
Expert Testimony | 1 | 2010 | 364 | 0.300 |
Why?
|
Drug Hypersensitivity | 5 | 2019 | 917 | 0.290 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 2270 | 0.290 |
Why?
|
Group V Phospholipases A2 | 3 | 2017 | 23 | 0.280 |
Why?
|
Dermatophagoides farinae | 2 | 2019 | 19 | 0.270 |
Why?
|
Immune Tolerance | 2 | 2017 | 2299 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-kit | 4 | 2011 | 727 | 0.270 |
Why?
|
Anaphylaxis | 3 | 2011 | 757 | 0.270 |
Why?
|
T-Lymphocyte Subsets | 2 | 2013 | 1798 | 0.270 |
Why?
|
Interleukin-3 | 5 | 2001 | 425 | 0.270 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 2 | 2024 | 57 | 0.260 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2003 | 97 | 0.260 |
Why?
|
Receptors, Prostaglandin E | 1 | 2005 | 56 | 0.260 |
Why?
|
Myeloid Progenitor Cells | 1 | 2006 | 112 | 0.260 |
Why?
|
Histamine Release | 2 | 2021 | 134 | 0.250 |
Why?
|
Goblet Cells | 4 | 2020 | 298 | 0.250 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2019 | 755 | 0.250 |
Why?
|
Piperazines | 2 | 2015 | 2521 | 0.250 |
Why?
|
Liver Transplantation | 2 | 2012 | 2329 | 0.250 |
Why?
|
PPAR gamma | 1 | 2008 | 484 | 0.240 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3680 | 0.240 |
Why?
|
Adenine Nucleotides | 1 | 2004 | 111 | 0.240 |
Why?
|
Urticaria | 1 | 2006 | 150 | 0.240 |
Why?
|
SRS-A | 1 | 2004 | 132 | 0.240 |
Why?
|
Lipids | 2 | 2013 | 3332 | 0.230 |
Why?
|
Lipoxygenase | 2 | 2022 | 72 | 0.230 |
Why?
|
Oncostatin M | 1 | 2024 | 42 | 0.230 |
Why?
|
Gene Expression Regulation | 7 | 2016 | 11874 | 0.230 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2005 | 332 | 0.220 |
Why?
|
Arachidonic Acid | 2 | 2022 | 427 | 0.220 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Leukocytes | 1 | 2012 | 2023 | 0.220 |
Why?
|
Cyclooxygenase 2 | 2 | 2018 | 596 | 0.220 |
Why?
|
Ovalbumin | 3 | 2015 | 675 | 0.220 |
Why?
|
Thromboxanes | 1 | 2023 | 45 | 0.220 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2010 | 1492 | 0.220 |
Why?
|
Mice, Mutant Strains | 4 | 2017 | 1748 | 0.220 |
Why?
|
Olfactory Mucosa | 1 | 2024 | 101 | 0.220 |
Why?
|
Picornaviridae Infections | 1 | 2024 | 95 | 0.220 |
Why?
|
Paranasal Sinuses | 1 | 2006 | 265 | 0.220 |
Why?
|
Lymphocyte Activation | 3 | 2013 | 5463 | 0.210 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
Hypersensitivity, Immediate | 2 | 2022 | 347 | 0.210 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2022 | 57 | 0.210 |
Why?
|
Rhinovirus | 1 | 2024 | 203 | 0.210 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2004 | 195 | 0.210 |
Why?
|
Allergy and Immunology | 2 | 2017 | 176 | 0.210 |
Why?
|
Quinolines | 4 | 2018 | 764 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.210 |
Why?
|
Cold Temperature | 1 | 2006 | 784 | 0.200 |
Why?
|
Cathepsin G | 1 | 2022 | 31 | 0.200 |
Why?
|
Chemokines, CC | 2 | 2007 | 283 | 0.200 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2013 | 318 | 0.200 |
Why?
|
Mitosis | 1 | 2007 | 1187 | 0.200 |
Why?
|
Nose | 1 | 2006 | 521 | 0.200 |
Why?
|
Cell Movement | 4 | 2017 | 5200 | 0.190 |
Why?
|
Male | 35 | 2024 | 360358 | 0.190 |
Why?
|
United States | 12 | 2017 | 72272 | 0.190 |
Why?
|
CHO Cells | 3 | 2012 | 1387 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4366 | 0.190 |
Why?
|
Bone Marrow Cells | 4 | 2021 | 2409 | 0.180 |
Why?
|
Cell Count | 3 | 2021 | 1835 | 0.180 |
Why?
|
Ligands | 3 | 2019 | 3268 | 0.180 |
Why?
|
Alternaria | 2 | 2017 | 42 | 0.180 |
Why?
|
Cricetinae | 3 | 2012 | 2424 | 0.180 |
Why?
|
Triazines | 1 | 2002 | 311 | 0.180 |
Why?
|
Cell Differentiation | 9 | 2024 | 11514 | 0.180 |
Why?
|
Interleukin-5 Receptor alpha Subunit | 1 | 2020 | 17 | 0.180 |
Why?
|
Integrins | 2 | 2012 | 834 | 0.180 |
Why?
|
Biological Evolution | 1 | 2006 | 1070 | 0.170 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2019 | 21 | 0.170 |
Why?
|
Receptors, Fc | 1 | 2003 | 534 | 0.170 |
Why?
|
Cell Adhesion Molecules | 2 | 2006 | 1602 | 0.170 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2015 | 1128 | 0.170 |
Why?
|
Cell Proliferation | 7 | 2024 | 10432 | 0.170 |
Why?
|
Receptors, IgE | 3 | 2011 | 375 | 0.170 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4174 | 0.170 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2023 | 311 | 0.160 |
Why?
|
Infant | 6 | 2021 | 36152 | 0.160 |
Why?
|
Hematopoietic Stem Cells | 4 | 2019 | 3394 | 0.160 |
Why?
|
Respiratory System | 2 | 2022 | 563 | 0.160 |
Why?
|
Phospholipases A2, Cytosolic | 1 | 2018 | 3 | 0.160 |
Why?
|
Receptors, CCR3 | 4 | 2003 | 62 | 0.160 |
Why?
|
Female | 33 | 2024 | 392148 | 0.160 |
Why?
|
Adenosine Diphosphate | 2 | 2013 | 422 | 0.160 |
Why?
|
Diet | 1 | 2017 | 8048 | 0.160 |
Why?
|
Enterocytes | 1 | 2020 | 220 | 0.160 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2022 | 1250 | 0.150 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 363 | 0.150 |
Why?
|
Cell Lineage | 3 | 2021 | 2554 | 0.150 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2014 | 485 | 0.150 |
Why?
|
Exocytosis | 3 | 2005 | 320 | 0.150 |
Why?
|
beta 2-Microglobulin | 4 | 2001 | 328 | 0.150 |
Why?
|
Skin Irritancy Tests | 1 | 2017 | 4 | 0.150 |
Why?
|
Propionates | 3 | 2003 | 183 | 0.140 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1997 | 141 | 0.140 |
Why?
|
Laminin | 2 | 1996 | 408 | 0.140 |
Why?
|
Consensus | 2 | 2017 | 3117 | 0.140 |
Why?
|
Acetates | 1 | 2018 | 321 | 0.140 |
Why?
|
Arachidonate 5-Lipoxygenase | 2 | 2012 | 128 | 0.140 |
Why?
|
Interleukins | 1 | 2021 | 783 | 0.140 |
Why?
|
Mice, Inbred BALB C | 8 | 2015 | 6188 | 0.140 |
Why?
|
Biological Assay | 1 | 2019 | 626 | 0.140 |
Why?
|
Egg Hypersensitivity | 1 | 2017 | 47 | 0.140 |
Why?
|
Immunologic Factors | 1 | 2006 | 1589 | 0.130 |
Why?
|
Mice, Transgenic | 6 | 2021 | 9529 | 0.130 |
Why?
|
Recombinant Proteins | 7 | 2009 | 6520 | 0.130 |
Why?
|
Interferon Type I | 1 | 2020 | 557 | 0.130 |
Why?
|
Societies, Scientific | 1 | 2017 | 222 | 0.130 |
Why?
|
Receptors, Prostaglandin E, EP3 Subtype | 1 | 2015 | 22 | 0.130 |
Why?
|
Virulence | 1 | 2019 | 1299 | 0.130 |
Why?
|
Flow Cytometry | 4 | 2021 | 5863 | 0.130 |
Why?
|
Nutritional Sciences | 1 | 2017 | 144 | 0.130 |
Why?
|
Proteoglycans | 2 | 1996 | 803 | 0.130 |
Why?
|
Receptors, Prostaglandin | 1 | 2015 | 53 | 0.120 |
Why?
|
HIV | 1 | 2002 | 1579 | 0.120 |
Why?
|
Cell Degranulation | 2 | 2022 | 277 | 0.120 |
Why?
|
Platelet Activating Factor | 1 | 2015 | 143 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 586 | 0.120 |
Why?
|
Antibody Specificity | 1 | 2017 | 1058 | 0.120 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2447 | 0.120 |
Why?
|
Collagen | 5 | 1998 | 2634 | 0.120 |
Why?
|
Ribonucleases | 1 | 1995 | 277 | 0.120 |
Why?
|
Integrin alpha4 | 2 | 2006 | 87 | 0.120 |
Why?
|
Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2013 | 10 | 0.120 |
Why?
|
RNA, Messenger | 7 | 2016 | 12758 | 0.120 |
Why?
|
Eczema | 1 | 2017 | 246 | 0.110 |
Why?
|
Echium | 1 | 2013 | 3 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2024 | 3206 | 0.110 |
Why?
|
Receptors, Interleukin-4 | 2 | 2005 | 64 | 0.110 |
Why?
|
gamma-Linolenic Acid | 1 | 2013 | 16 | 0.110 |
Why?
|
Lipoxygenases | 1 | 2013 | 13 | 0.110 |
Why?
|
Cell Division | 4 | 2004 | 4457 | 0.110 |
Why?
|
Child | 10 | 2024 | 80079 | 0.110 |
Why?
|
Fibronectins | 1 | 1997 | 723 | 0.110 |
Why?
|
Airway Obstruction | 1 | 2018 | 661 | 0.110 |
Why?
|
Cell Line | 7 | 2020 | 15576 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 1 | 2018 | 574 | 0.110 |
Why?
|
Platelet Factor 4 | 1 | 2013 | 129 | 0.110 |
Why?
|
Fibroblasts | 3 | 2024 | 4137 | 0.110 |
Why?
|
Adult | 19 | 2024 | 220969 | 0.110 |
Why?
|
Middle Aged | 18 | 2024 | 220584 | 0.110 |
Why?
|
Receptors, Prostaglandin E, EP1 Subtype | 1 | 2012 | 9 | 0.110 |
Why?
|
Mucins | 1 | 2016 | 568 | 0.100 |
Why?
|
Leukotriene B4 | 1 | 2014 | 280 | 0.100 |
Why?
|
Plant Oils | 1 | 2013 | 198 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2002 | 1906 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2012 | 18221 | 0.100 |
Why?
|
Airway Resistance | 1 | 2013 | 406 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 888 | 0.100 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 2012 | 34 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2018 | 2079 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1009 | 0.100 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 1457 | 0.090 |
Why?
|
Bronchoconstriction | 1 | 2012 | 142 | 0.090 |
Why?
|
P-Selectin | 1 | 2013 | 599 | 0.090 |
Why?
|
Platelet-Rich Plasma | 1 | 2013 | 178 | 0.090 |
Why?
|
Endoscopy | 1 | 2021 | 1851 | 0.090 |
Why?
|
Phospholipases A2, Secretory | 1 | 2010 | 30 | 0.090 |
Why?
|
Pyrimidines | 2 | 2011 | 3027 | 0.090 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1788 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2013 | 2745 | 0.090 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 370 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1110 | 0.090 |
Why?
|
Macrophage Activation | 1 | 2013 | 552 | 0.090 |
Why?
|
Up-Regulation | 3 | 2020 | 4117 | 0.090 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4533 | 0.090 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4433 | 0.080 |
Why?
|
Arthritis, Experimental | 1 | 2012 | 291 | 0.080 |
Why?
|
Lymphocytes | 1 | 2017 | 2604 | 0.080 |
Why?
|
Lymphoid Tissue | 1 | 2011 | 445 | 0.080 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2009 | 67 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12142 | 0.080 |
Why?
|
Transcriptional Activation | 2 | 2007 | 1755 | 0.080 |
Why?
|
Amino Acid Sequence | 4 | 2023 | 13441 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2202 | 0.080 |
Why?
|
Aged | 10 | 2024 | 169042 | 0.080 |
Why?
|
Young Adult | 6 | 2021 | 59179 | 0.080 |
Why?
|
Protein Kinase C | 1 | 2013 | 1202 | 0.080 |
Why?
|
Metaplasia | 1 | 2009 | 322 | 0.080 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 115 | 0.080 |
Why?
|
HeLa Cells | 2 | 2007 | 3087 | 0.080 |
Why?
|
Exanthema | 2 | 2003 | 503 | 0.080 |
Why?
|
Food Labeling | 1 | 2011 | 179 | 0.080 |
Why?
|
STAT1 Transcription Factor | 1 | 2009 | 340 | 0.070 |
Why?
|
Hyperplasia | 2 | 2018 | 1150 | 0.070 |
Why?
|
Cell Adhesion | 3 | 2002 | 3088 | 0.070 |
Why?
|
Cricetulus | 1 | 2009 | 814 | 0.070 |
Why?
|
Guinea Pigs | 1 | 2009 | 1310 | 0.070 |
Why?
|
Histamine | 2 | 2022 | 499 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5789 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2015 | 2690 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2018 | 12334 | 0.070 |
Why?
|
Neutrophils | 2 | 2024 | 3763 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 17878 | 0.070 |
Why?
|
MAP Kinase Signaling System | 2 | 2005 | 1483 | 0.070 |
Why?
|
Rhinitis, Atrophic | 1 | 2006 | 2 | 0.070 |
Why?
|
Phosphorylation | 3 | 2013 | 8311 | 0.070 |
Why?
|
Rhinomanometry | 1 | 2006 | 6 | 0.070 |
Why?
|
Serine Endopeptidases | 2 | 2020 | 1022 | 0.070 |
Why?
|
Cytoplasmic Granules | 2 | 2001 | 573 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4571 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2012 | 1890 | 0.060 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3088 | 0.060 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3209 | 0.060 |
Why?
|
Immunotherapy | 2 | 2012 | 4642 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3419 | 0.060 |
Why?
|
Bronchi | 1 | 2009 | 846 | 0.060 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 2005 | 88 | 0.060 |
Why?
|
Th17 Cells | 1 | 2012 | 793 | 0.060 |
Why?
|
Receptors, Eicosanoid | 1 | 2005 | 12 | 0.060 |
Why?
|
Child, Preschool | 3 | 2017 | 42188 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 3 | 2017 | 5672 | 0.060 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2004 | 44 | 0.060 |
Why?
|
Receptors, Purinergic P2Y1 | 1 | 2004 | 40 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2005 | 4341 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2013 | 11069 | 0.060 |
Why?
|
Nasal Septum | 1 | 2006 | 130 | 0.060 |
Why?
|
Gene Silencing | 1 | 2011 | 1503 | 0.060 |
Why?
|
Adolescent | 8 | 2020 | 88234 | 0.060 |
Why?
|
Methacholine Chloride | 2 | 2017 | 220 | 0.060 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2009 | 365 | 0.060 |
Why?
|
CD40 Ligand | 1 | 2006 | 521 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6305 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1896 | 0.060 |
Why?
|
HIV-1 | 1 | 2001 | 6858 | 0.060 |
Why?
|
Mitochondrial Proteins | 1 | 2010 | 974 | 0.060 |
Why?
|
Leukocyte Count | 3 | 2015 | 1597 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18381 | 0.060 |
Why?
|
Laryngectomy | 1 | 2006 | 243 | 0.060 |
Why?
|
Pulmonary Ventilation | 1 | 2006 | 372 | 0.060 |
Why?
|
Protein Binding | 2 | 2007 | 9345 | 0.060 |
Why?
|
Cell Survival | 2 | 2009 | 5780 | 0.060 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 17629 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8645 | 0.050 |
Why?
|
Olfaction Disorders | 1 | 2006 | 224 | 0.050 |
Why?
|
Umbilical Cord | 1 | 2004 | 177 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 2 | 2013 | 1835 | 0.050 |
Why?
|
Microscopy, Immunoelectron | 1 | 2003 | 317 | 0.050 |
Why?
|
Dendritic Cells | 2 | 2013 | 2722 | 0.050 |
Why?
|
Models, Biological | 3 | 2013 | 9461 | 0.050 |
Why?
|
Trichinellosis | 1 | 2002 | 27 | 0.050 |
Why?
|
Trichinella spiralis | 1 | 2002 | 22 | 0.050 |
Why?
|
Nutritional Status | 1 | 2011 | 1596 | 0.050 |
Why?
|
Gene Expression | 1 | 2015 | 7568 | 0.050 |
Why?
|
Adoptive Transfer | 2 | 2017 | 818 | 0.050 |
Why?
|
Immunity | 1 | 2008 | 994 | 0.050 |
Why?
|
Carbachol | 1 | 2022 | 223 | 0.050 |
Why?
|
Risk Factors | 4 | 2024 | 74115 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10754 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2008 | 3591 | 0.050 |
Why?
|
Receptors, Neuropeptide | 1 | 2022 | 106 | 0.050 |
Why?
|
Models, Immunological | 1 | 2004 | 512 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 12966 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2023 | 219 | 0.050 |
Why?
|
DNA Primers | 2 | 2004 | 2817 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5835 | 0.050 |
Why?
|
Umbilical Veins | 1 | 2002 | 426 | 0.050 |
Why?
|
Cell Separation | 2 | 1998 | 1718 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2014 | 0.050 |
Why?
|
Antibodies, Monoclonal | 3 | 2009 | 9172 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2218 | 0.050 |
Why?
|
Monocytes | 2 | 2001 | 2565 | 0.050 |
Why?
|
Influenza, Human | 2 | 2024 | 1518 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2010 | 2446 | 0.050 |
Why?
|
Apoptosis | 3 | 2004 | 9476 | 0.050 |
Why?
|
Integrin beta Chains | 1 | 2021 | 115 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2013 | 3411 | 0.040 |
Why?
|
Receptors, Cytokine | 1 | 2001 | 257 | 0.040 |
Why?
|
Pulmonary Fibrosis | 1 | 2004 | 505 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2004 | 927 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2003 | 3705 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2004 | 963 | 0.040 |
Why?
|
5-Lipoxygenase-Activating Proteins | 2 | 1996 | 24 | 0.040 |
Why?
|
Anti-Allergic Agents | 2 | 2013 | 153 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2000 | 96 | 0.040 |
Why?
|
Drug Combinations | 2 | 1996 | 2048 | 0.040 |
Why?
|
Receptors, Interleukin-3 | 1 | 1999 | 29 | 0.040 |
Why?
|
E-Selectin | 1 | 2002 | 577 | 0.040 |
Why?
|
Leukemia | 1 | 2008 | 1520 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 624 | 0.040 |
Why?
|
Drug Eruptions | 1 | 2002 | 335 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 2001 | 486 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7995 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2023 | 836 | 0.040 |
Why?
|
HIV Infections | 2 | 2020 | 17337 | 0.040 |
Why?
|
Thymidine | 1 | 1998 | 297 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1242 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2004 | 1988 | 0.040 |
Why?
|
Phenotype | 3 | 2003 | 16571 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2022 | 949 | 0.040 |
Why?
|
Desensitization, Immunologic | 2 | 2014 | 556 | 0.040 |
Why?
|
Immediate-Early Proteins | 1 | 2001 | 444 | 0.040 |
Why?
|
Sulfides | 1 | 2018 | 169 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2005 | 1971 | 0.040 |
Why?
|
Serotonin | 1 | 2022 | 1041 | 0.040 |
Why?
|
Chemokine CCL11 | 1 | 1997 | 128 | 0.040 |
Why?
|
Antibodies | 3 | 2020 | 2414 | 0.040 |
Why?
|
Down-Regulation | 1 | 2004 | 2915 | 0.040 |
Why?
|
Imidazoles | 1 | 2003 | 1175 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2012 | 2423 | 0.040 |
Why?
|
Integrin alpha4beta1 | 1 | 1997 | 119 | 0.040 |
Why?
|
Bronchial Provocation Tests | 1 | 2017 | 216 | 0.040 |
Why?
|
Skin Diseases | 1 | 1986 | 1094 | 0.040 |
Why?
|
Guanidines | 1 | 1998 | 194 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 778 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2018 | 432 | 0.030 |
Why?
|
Calcimycin | 1 | 1996 | 213 | 0.030 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2006 | 1073 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2001 | 2178 | 0.030 |
Why?
|
Ionophores | 1 | 1996 | 107 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2000 | 584 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2002 | 1674 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2001 | 727 | 0.030 |
Why?
|
Phospholipases A2 | 1 | 1996 | 197 | 0.030 |
Why?
|
Cell Death | 1 | 2002 | 1677 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2020 | 639 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2004 | 26180 | 0.030 |
Why?
|
Plasma Cells | 1 | 2020 | 597 | 0.030 |
Why?
|
Prostaglandins D | 1 | 2015 | 27 | 0.030 |
Why?
|
Enzyme Induction | 1 | 1996 | 452 | 0.030 |
Why?
|
Syndrome | 1 | 2002 | 3268 | 0.030 |
Why?
|
Phospholipases A | 1 | 1996 | 204 | 0.030 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 393 | 0.030 |
Why?
|
Virginia | 1 | 2016 | 115 | 0.030 |
Why?
|
Lung Diseases | 1 | 2006 | 1909 | 0.030 |
Why?
|
Eosinophil-Derived Neurotoxin | 1 | 1995 | 13 | 0.030 |
Why?
|
Eosinophil Peroxidase | 1 | 1995 | 21 | 0.030 |
Why?
|
Stromal Cells | 1 | 2001 | 1329 | 0.030 |
Why?
|
Skin | 1 | 2009 | 4473 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2872 | 0.030 |
Why?
|
Risk Assessment | 1 | 2017 | 23972 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3777 | 0.030 |
Why?
|
Base Sequence | 2 | 2004 | 12421 | 0.030 |
Why?
|
Peroxidases | 1 | 1995 | 134 | 0.030 |
Why?
|
Cell Communication | 1 | 2002 | 1654 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1996 | 386 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2003 | 1879 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15498 | 0.030 |
Why?
|
Drug Synergism | 1 | 1998 | 1755 | 0.030 |
Why?
|
Neurotoxins | 1 | 1995 | 240 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3688 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1217 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2002 | 9586 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1995 | 522 | 0.030 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2013 | 64 | 0.030 |
Why?
|
Amyloidosis | 2 | 1998 | 815 | 0.030 |
Why?
|
Virus Replication | 1 | 2001 | 2427 | 0.030 |
Why?
|
Prospective Studies | 3 | 2023 | 54360 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3794 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2020 | 2328 | 0.030 |
Why?
|
Hematopoiesis | 2 | 2010 | 2049 | 0.030 |
Why?
|
Transfection | 1 | 2001 | 5766 | 0.030 |
Why?
|
Seeds | 1 | 2013 | 122 | 0.030 |
Why?
|
alpha-Linolenic Acid | 1 | 2013 | 144 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 1963 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1055 | 0.030 |
Why?
|
Trans-Activators | 1 | 2002 | 2852 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15908 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2017 | 1814 | 0.020 |
Why?
|
Calcium | 2 | 2013 | 5717 | 0.020 |
Why?
|
Interleukin-1 | 3 | 2001 | 1248 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2001 | 2894 | 0.020 |
Why?
|
Capillary Permeability | 1 | 2015 | 773 | 0.020 |
Why?
|
Transcription Factors | 2 | 2002 | 12116 | 0.020 |
Why?
|
Pyridines | 1 | 2003 | 2874 | 0.020 |
Why?
|
Antigens, CD | 1 | 2002 | 3998 | 0.020 |
Why?
|
Edema | 1 | 2015 | 765 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2013 | 10175 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2012 | 817 | 0.020 |
Why?
|
Staining and Labeling | 1 | 1995 | 1081 | 0.020 |
Why?
|
Chimera | 1 | 2012 | 453 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3085 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 502 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2013 | 584 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 774 | 0.020 |
Why?
|
Dermatophagoides pteronyssinus | 1 | 2010 | 11 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4010 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2013 | 540 | 0.020 |
Why?
|
Administration, Intranasal | 1 | 2012 | 476 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3077 | 0.020 |
Why?
|
Carcinogens | 1 | 2012 | 452 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4408 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 2013 | 561 | 0.020 |
Why?
|
Superoxides | 2 | 2001 | 387 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22148 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1914 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2013 | 734 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1608 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2467 | 0.020 |
Why?
|
Isoenzymes | 1 | 2013 | 1687 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 1759 | 0.020 |
Why?
|
Chemokine CCL1 | 1 | 2007 | 20 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9311 | 0.020 |
Why?
|
Receptors, CCR8 | 1 | 2007 | 28 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9417 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10073 | 0.020 |
Why?
|
Rats, Inbred WKY | 1 | 2007 | 150 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2010 | 390 | 0.020 |
Why?
|
Renal Dialysis | 1 | 1997 | 1799 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8833 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7583 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2010 | 661 | 0.020 |
Why?
|
Dust | 1 | 2010 | 487 | 0.020 |
Why?
|
Tuberculosis | 1 | 2020 | 2015 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1683 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3742 | 0.020 |
Why?
|
Carrier Proteins | 2 | 1996 | 4935 | 0.020 |
Why?
|
Mucoproteins | 1 | 2006 | 49 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10548 | 0.020 |
Why?
|
Acute Lung Injury | 1 | 2010 | 367 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10505 | 0.020 |
Why?
|
Methods | 1 | 1986 | 1065 | 0.020 |
Why?
|
Benzamides | 1 | 2011 | 1371 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2577 | 0.020 |
Why?
|
Trachea | 1 | 2011 | 1089 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4803 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2286 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2010 | 1250 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58894 | 0.010 |
Why?
|
Glycosylation | 2 | 1998 | 1098 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5780 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2009 | 1865 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 80566 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2013 | 1390 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 12943 | 0.010 |
Why?
|
Pedigree | 1 | 2011 | 4539 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5034 | 0.010 |
Why?
|
Receptors, Immunologic | 2 | 2001 | 1409 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 1662 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15689 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4570 | 0.010 |
Why?
|
Receptors, Interleukin-13 | 1 | 2002 | 13 | 0.010 |
Why?
|
Interleukin-13 Receptor alpha1 Subunit | 1 | 2002 | 23 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1998 | 4236 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15828 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2006 | 1336 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2002 | 194 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4391 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 2002 | 243 | 0.010 |
Why?
|
Early Growth Response Protein 1 | 1 | 2001 | 133 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2001 | 216 | 0.010 |
Why?
|
Larva | 1 | 2002 | 508 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10704 | 0.010 |
Why?
|
Acid Phosphatase | 1 | 2000 | 139 | 0.010 |
Why?
|
Intracellular Membranes | 1 | 2001 | 389 | 0.010 |
Why?
|
Vacuoles | 1 | 2000 | 228 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16967 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2006 | 6126 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2000 | 602 | 0.010 |
Why?
|
Cell Size | 1 | 2000 | 624 | 0.010 |
Why?
|
Procollagen | 1 | 1998 | 187 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 3730 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2000 | 2561 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2001 | 1605 | 0.010 |
Why?
|
Pediatrics | 1 | 2011 | 3588 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1996 | 422 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 1998 | 685 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1996 | 851 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13347 | 0.010 |
Why?
|
Lysosomes | 1 | 2001 | 924 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1998 | 699 | 0.010 |
Why?
|
Kidney Failure, Chronic | 2 | 1998 | 2477 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1996 | 1058 | 0.010 |
Why?
|
Rodentia | 1 | 1996 | 261 | 0.010 |
Why?
|
Immunoblotting | 1 | 1998 | 1646 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2003 | 2160 | 0.010 |
Why?
|
Introns | 1 | 1996 | 968 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2006 | 4745 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1996 | 2747 | 0.010 |
Why?
|
Rats | 1 | 2007 | 23717 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2000 | 2802 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1998 | 3800 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1996 | 4172 | 0.010 |
Why?
|
Exons | 1 | 1996 | 2381 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1996 | 2509 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1998 | 6224 | 0.010 |
Why?
|
Cohort Studies | 1 | 2012 | 41457 | 0.000 |
Why?
|
Time Factors | 2 | 2001 | 39913 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1996 | 4611 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6074 | 0.000 |
Why?
|
Glucose | 1 | 1998 | 4345 | 0.000 |
Why?
|